Alto Neuroscience Stock Rockets Nearly 80% on Game-Changing FDA Nod for Depression Treatment Push
Hey, folks, buckle up because the market’s throwing us a curveball today that’s got biotech investors buzzing like crazy. As of this writing, shares of Alto Neuroscience (NYSE: ANRO) are up a whopping 79.93%, trading around $10.94 after adding $4.86 in the morning session. That’s the kind of move that makes you spill your coffee … Read more